InflaRx N.V. Announces Annual Shareholder Meeting
Ticker: IFRX · Form: 6-K · Filed: Apr 4, 2024 · CIK: 1708688
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
TL;DR
InflaRx N.V. is holding its annual shareholder meeting on April 25, 2024.
AI Summary
InflaRx N.V. filed a Form 6-K on April 4, 2024, to announce its annual general meeting of shareholders scheduled for April 25, 2024. The company also made certain related materials available to shareholders, which are attached as exhibits to the filing.
Why It Matters
This filing informs shareholders about the upcoming annual meeting and provides them with necessary materials for participation and voting.
Risk Assessment
Risk Level: low — The filing is procedural, announcing a shareholder meeting and related materials, with no new financial or operational information that would typically indicate higher risk.
Key Players & Entities
- InflaRx N.V. (company) — Filer of the 6-K and company holding the shareholder meeting
- April 25, 2024 (date) — Date of the annual general meeting of shareholders
- April 4, 2024 (date) — Date of the 6-K filing and convening notice
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report that InflaRx N.V. convened its annual general meeting of shareholders on April 4, 2024, and made certain related materials available to shareholders.
When is the annual general meeting of shareholders scheduled to be held?
The annual general meeting of shareholders is scheduled to be held on April 25, 2024.
What exhibits are attached to this Form 6-K?
The exhibits attached to this Form 6-K are Exhibit 99.1, the Convening Notice including Agenda and Explanatory Notes, and Exhibit 99.2, the Voting Proxy.
What is the company's principal executive office address?
The company's principal executive office address is Winzerlaer Str. 2, 07745 Jena, Germany.
Does InflaRx N.V. file annual reports under Form 20-F?
Yes, InflaRx N.V. indicates by check mark that it files annual reports under cover of Form 20-F.
Filing Stats: 199 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-04-04 16:01:44
Filing Documents
- ny20020632x1_6k.htm (6-K) — 18KB
- ny20020632x1_ex99-1.htm (EX-99.1) — 41KB
- ny20020632x1_ex99-2.htm (EX-99.2) — 43KB
- 0001140361-24-017927.txt ( ) — 102KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INFLARX N.V. Date: April 4, 2024 By: /s/ Niels Riedemann Name: Niels Riedemann Title: Chief Executive Officer